Jonathan M. is a clinical scientist currently serving as the Director at REGENXBIO, specializing in clinical trial operations and drug development. With a strong background in academia and the pharmaceutical industry, Jonathan has demonstrated expertise in gene therapy, oncology, and pediatric neuromuscular disorders. Previously, Jonathan held various roles at Novartis, including Associate Clinical Development Director and Expert Global Trial Manager. Jonathan earned a Master of Arts in Biotechnology from Columbia University and is pursuing a PhD in Clinical Research at the Icahn School of Medicine at Mount Sinai.
This person is not in any teams
This person is not in any offices